Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 6.99 USD -1.55%
Market Cap: 1.1B USD

Intrinsic Value

The intrinsic value of one XERS stock under the Base Case scenario is hidden USD. Compared to the current market price of 6.99 USD, Xeris Biopharma Holdings Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

XERS Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Xeris Biopharma Holdings Inc

Intrinsic Value History
Dive into the past to invest in the future

XERS looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether XERS usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about XERS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is XERS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Xeris Biopharma Holdings Inc.

Explain Valuation
Compare XERS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about XERS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Xeris Biopharma Holdings Inc

Current Assets 224m
Cash & Short-Term Investments 91.6m
Receivables 53.8m
Other Current Assets 78.7m
Non-Current Assets 146.2m
PP&E 27.2m
Intangibles 113.6m
Other Non-Current Assets 5.3m
Current Liabilities 116.2m
Accounts Payable 6.5m
Accrued Liabilities 107m
Other Current Liabilities 2.6m
Non-Current Liabilities 254.9m
Long-Term Debt 219.5m
Other Non-Current Liabilities 35.4m
Efficiency

Free Cash Flow Analysis
Xeris Biopharma Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Xeris Biopharma Holdings Inc

Revenue
266.1m USD
Cost of Revenue
-41.1m USD
Gross Profit
225m USD
Operating Expenses
-215.2m USD
Operating Income
9.8m USD
Other Expenses
-25.4m USD
Net Income
-15.6m USD
Fundamental Scores

XERS Profitability Score
Profitability Due Diligence

Xeris Biopharma Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Xeris Biopharma Holdings Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

XERS Solvency Score
Solvency Due Diligence

Xeris Biopharma Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
hidden
Solvency
Score

Xeris Biopharma Holdings Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XERS Price Targets Summary
Xeris Biopharma Holdings Inc

Wall Street analysts forecast XERS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XERS is 11.73 USD with a low forecast of 8.08 USD and a high forecast of 18.9 USD.

Lowest
Price Target
8.08 USD
16% Upside
Average
Price Target
11.73 USD
68% Upside
Highest
Price Target
18.9 USD
170% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Xeris Biopharma Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for XERS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

XERS Insider Trading
Buy and sell transactions by insiders

XERS News

What is the Intrinsic Value of one XERS stock?

The intrinsic value of one XERS stock under the Base Case scenario is hidden USD.

Is XERS stock undervalued or overvalued?

Compared to the current market price of 6.99 USD, Xeris Biopharma Holdings Inc is hidden .

Back to Top